[HTML][HTML] The sirtuin family in health and disease

QJ Wu, TN Zhang, HH Chen, XF Yu, JL Lv… - Signal transduction and …, 2022 - nature.com
Sirtuins (SIRTs) are nicotine adenine dinucleotide (+)-dependent histone deacetylases
regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in …

[HTML][HTML] Vorinostat (SAHA) and breast cancer: an overview

A Wawruszak, L Borkiewicz, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer (BC) is the most frequent malignancy diagnosed in 2020
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …

NAD metabolism in aging and cancer

JWR Kincaid, NA Berger - Experimental Biology and …, 2020 - journals.sagepub.com
NAD+ and its derivatives NADH, NADP+, and NADPH are essential cofactors in redox
reactions and electron transport pathways. NAD serves also as substrate for an extensive …

[HTML][HTML] Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 …

Y Zhao, X Ye, R Chen, Q Gao, D Zhao… - Oncology …, 2020 - spandidos-publications.com
Increasing evidence has indicated the roles of sirtuin 7 (SIRT7) in numerous human
cancers. However, the effects and the clinical significance of SIRT7 in human lung cancer is …

Oncogenic SIRT7 inhibits GATA4 transcriptional activity and activates the Wnt signaling pathway in ovarian cancer

G Li, W Xu, X Li, M Chen, Y Shi, M Wei, D Peng - Gynecologic Oncology, 2023 - Elsevier
Abstract Objective Sirtuin-7 (SIRT7) is a class III histone deacetylase that plays an important
role in cancer development and frequently overexpressed in carcinomas. In this study, the …

Downregulation of fibroblast growth factor 5 inhibits cell growth and invasion of human nonsmall‐cell lung cancer cells

Y Zhou, Q Yu, Y Chu, X Zhu, J Deng… - Journal of Cellular …, 2019 - Wiley Online Library
The morbidity and mortality rates of nonsmall‐cell lung cancer (NSCLC) have increased in
recent years. We aimed to explore the biological role of fibroblast growth factor 5 (FGF5) in …

[HTML][HTML] Sirtuins and hypoxia in EMT control

M Aventaggiato, F Barreca, L Sansone, L Pellegrini… - Pharmaceuticals, 2022 - mdpi.com
Epithelial–mesenchymal transition (EMT), a physiological process during embryogenesis,
can become pathological in the presence of different driving forces. Reduced oxygen …

[HTML][HTML] YZL-51N functions as a selective inhibitor of SIRT7 by NAD+ competition to impede DNA damage repair

TS Kang, YM Yan, Y Tian, J Zhang, M Zhang, Y Shu… - iScience, 2024 - cell.com
The NAD+-dependent deacetylase SIRT7 is a pivotal regulator of DNA damage response
(DDR) and a promising drug target for developing cancer therapeutics. However, limited …

Association of sirtuins (SIRT1-7) with lung and intestinal diseases

Y Chen, D Zhou, Y Feng, B Li, Y Cui, G Chen… - Molecular and Cellular …, 2022 - Springer
Abstract “Exterior-interior correlation between the lung and large intestine” is one of the
important contents of traditional Chinese medicine. This theory describes the role of the lung …

Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma

M Yanai, M Kurata, Y Muto, H Iha, T Kanao… - Pathology, 2020 - Elsevier
Summary Sirtuin 7 (SIRT7) is a NAD+ (nicotinamide adenine dinucleotide) dependent
deacetylase that is reported to contribute to tumour growth and invasion by selectively acting …